| Literature DB >> 27328903 |
Z Ebcioglu1,2, C Liu1, R Shapiro1, M Rana2, F Salem3, S Florman1, S Huprikar2, V Nair4,5.
Abstract
We report an HIV-positive renal transplant recipient with delayed graft function who was converted from tacrolimus to belatacept in an attempt to improve renal function. The patient had kidney biopsies at 4 and 8 weeks posttransplant that revealed acute tubular necrosis and mild fibrosis. After 14 weeks of delayed function, belatacept was initiated and tacrolimus was weaned off. Shortly after discontinuing tacrolimus, renal function began to improve. The patient was able to discontinue dialysis 21 weeks posttransplant. HIV viral load was undetectable at last follow-up. To our knowledge, this is the first report of belatacept use in a patient with HIV. © Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.Entities:
Keywords: clinical research/practice; delayed graft function (DGF); fusion proteins and monoclonal antibodies: belatacept; immunosuppressant; immunosuppression/immune modulation; immunosuppressive regimens; infection and infectious agents; infectious disease; kidney transplantation/nephrology; maintenance; viral: human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)
Mesh：
Substances：
Year: 2016 PMID： 27328903 DOI： 10.1111/ajt.13923
Source DB: PubMed Journal: Am J Transplant ISSN： 1600-6135 Impact factor: 8.086